Return to Today's science sparks archives

2015-07-01

Fig 1. Effect of Sirs on Transcription of a1.

Fig 1. Effect of Sirs on Transcription of a1.
  • Wang X, Bryant G, Zhao A, Ptashne M

  • Curr Biol. 2015 May 4;25(9):1215-20.

2015-07-02

Fig. 2. Microphotographs of a 5-cm invasive EFVPTC in a 62-year-old woman who presented with lung metastasis and a serum thyroglobulin level of 13 900 ng/mL.

Fig. 2. Microphotographs of a 5-cm invasive EFVPTC in a 62-year-old woman who presented with lung metastasis and a serum thyroglobulin level of 13 900 ng/mL.
  • Ganly I1, Wang L1, Tuttle RM2, Katabi N3, Ceballos GA4, Harach HR5, Ghossein R

  • Hum Pathol. 2015 May;46(5):657-64.

2015-07-06

Figure 1. Development stress promoting heightened allostatic load may result in diminished cognitive resources underlying adaptive coping with cancer stress and increased risk for cancer-related neurocognitive sequelae

Figure 1. Development stress promoting heightened allostatic load may result in diminished cognitive resources underlying adaptive coping with cancer stress and increased risk for cancer-related neurocognitive sequelae
  • Andreotti C, Root JC, Ahles TA, McEwen BS, Compas BE

  • Psychooncology. 2015 Jun;24(6):617-23.

2015-07-07

Fig. 1 Survival in patients with sporadic and familial MPNs.

Fig. 1 Survival in patients with sporadic and familial MPNs.
  • Hultcrantz M, Lund SH, Landgren O, Samuelsson J, Goldin LR, Oddsson A, Björkholm M, Kristinsson SY

  • Blood. 2015 Jun 4;125(23):3665-6.

2015-07-08

Fig 1. MW ablation performed with the probe in a perpendicular orientation and the ablation zone including the pleural puncture site.

Fig 1. MW ablation performed with the probe in a perpendicular orientation and the ablation zone including the pleural puncture site.
  • Lee KS, Takaki H, Yarmohammadi H, Srimathveeravalli G, Luchins K, Monette S, Nair S, Kishore S, Erinjeri JP

  • J Vasc Interv Radiol. 2015 Jul;26(7):1052-8.

2015-07-09

Fig 1. Sema 3A stimulates NRP-1-mediated PTEN phosphorylation and nuclear translocation in breast cancer cells.

Fig 1. Sema 3A stimulates NRP-1-mediated PTEN phosphorylation and nuclear translocation in breast cancer cells.
  • Mishra R, Thorat D, Soundararajan G, Pradhan SJ, Chakraborty G, Lohite K, Karnik S, Kundu GC

  • Oncogene. 2015 Mar 19;34(12):1584-95.

2015-07-10

Figure 1. Results of the final step of hierarchical linear regression analysis among (a) patients who quit smoking prior to diagnosis

Figure 1. Results of the final step of hierarchical linear regression analysis among (a) patients who quit smoking prior to diagnosis
  • Shen MJ, Coups EJ, Li Y, Holland JC, Hamann HA, Ostroff JS

  • Psychooncology. 2015 Jun;24(6):683-90.

2015-07-13

Fig 1. Screen for miRNAs impacting on endogenous p53 levels. Results of the screen for miRNAs impacting on p53 protein levels.

Fig 1. Screen for miRNAs impacting on endogenous p53 levels. Results of the screen for miRNAs impacting on p53 protein levels.
  • Jansson MD, Damas ND, Lees M, Jacobsen A, Lund AH

  • Oncogene. 2015 Apr 9;34(15):1908-18.

2015-07-14

Fig 1. Association between mutations or CNV and OS.

Fig 1. Association between mutations or CNV and OS.
  • Bellmunt J, Werner L, Leow JJ, Mullane SA, Fay AP, Riester M, Van Hummelen P, Taplin ME, Choueiri TK, Van Allen E, Rosenberg J

  • PLoS One. 2015 Jun 3;10(6):e0124711.
Open Access button

2015-07-15

Fig 1. Example of WBRT field used to treat a patient with PCNSL. The globes of the eyes are outlined.

Fig 1. Example of WBRT field used to treat a patient with PCNSL. The globes of the eyes are outlined.
  • Milgrom SA, Yahalom J

  • Leuk Lymphoma. 2015 May;56(5):1197-204.

2015-07-16

Fig 3. A) Symmetrical dermal melanocytic tumor with adipocytic metaplasia. B) Epithelioid melanocytes with enlarged nuclei. C) Tumor cells with abundant, ‘glassy’ cytoplasm. D) Melanocytes with nuclear pseudoinclusions, some with melanin pigment.

Fig 3. A) Symmetrical dermal melanocytic tumor with adipocytic metaplasia. B) Epithelioid melanocytes with enlarged nuclei. C) Tumor cells with abundant, ‘glassy’ cytoplasm. D) Melanocytes with nuclear pseudoinclusions, some with melanin pigment.
  • Marusic Z, Buljan M, Busam KJ

  • J Cutan Pathol. 2015 Jun;42(6):406-12.

2015-07-17

Fig 1. Transplanted peripheral blood progenitor cell dose (CD34+) and probability of platelet recovery (platelets ≥ 20 × 109/L).

Fig 1. Transplanted peripheral blood progenitor cell dose (CD34+) and probability of platelet recovery (platelets ≥ 20 × 109/L).
  • Sauter CS, Giralt S

  • Leuk Lymphoma. 2015 Jun;56(6):1619-25.

2015-07-20

Fig 1. Anti-CD19 CAR T cell (the third generation) recognizes CD19 antigen on a tumor cell via an anti-CD19 single chain Fv (scFv) binding domain.

Fig 1. Anti-CD19 CAR T cell (the third generation) recognizes CD19 antigen on a tumor cell via an anti-CD19 single chain Fv (scFv) binding domain.
  • Suzuki M, Curran KJ, Cheung NK

  • Pediatr Blood Cancer. 2015 Aug;62(8):1326-36.

2015-07-21

Fig 3. Percentage of abnormal plasma cells/all plasma cells within the bone marrow compartment (aPCs/BMPCs) by flow cytometry represented per patient, location and order of aspirate pull.

Fig 3. Percentage of abnormal plasma cells/all plasma cells within the bone marrow compartment (aPCs/BMPCs) by flow cytometry represented per patient, location and order of aspirate pull.
  • Manasanch EE, Salem DA, Yuan CM, Tageja N, Bhutani M, Kwok M, Kazandjian D, Carter G, Steinberg SM, Zuchlinski D, Mulquin M, Calvo K, Maric I, Roschewski M, Korde N, Braylan R, Landgren O, Stetler-Stevenson M

  • Leuk Lymphoma. 2015 May;56(5):1416-24.

2015-07-22

Fig 2. Best response, progression-free interval, and overall survival for individual patients.

Fig 2. Best response, progression-free interval, and overall survival for individual patients.
  • Johnson DB, Peng C, Abramson RG, Ye F, Zhao S, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE

  • Oncologist. 2015 Jun;20(6):648-52.

2015-07-23

Figure 1. The cumulative incidence of CMV infection in the first year after CBT in CMV seropositive recipients according to the method of monitoring.

Figure 1. The cumulative incidence of CMV infection in the first year after CBT in CMV seropositive recipients according to the method of monitoring.
  • Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, Scaradavou A, Kernan NA, O'Reilly RJ, Giralt S, Jakubowski A, Koehne G, Papadopoulos EB, Ponce DM, Sauter C, Papanicolaou G, Barker JN

  • Leuk Lymphoma. 2015 Jun;56(6):1799-805.

2015-07-24

Fig 4. Induction of anchorage-independent growth by SW620 and CRC-MF conditioned media was dependent on CXCL1.

Fig 4. Induction of anchorage-independent growth by SW620 and CRC-MF conditioned media was dependent on CXCL1.
  • le Rolle AF, Chiu TK, Fara M, Shia J, Zeng Z, Weiser MR, Paty PB, Chiu VK

  • J Transl Med. 2015 Jun 24;13:199.
Open Access button

2015-07-27

Fig 1A. 38-year-old female kidney donor. Segmentation of renal cortex. Only tissue not shaded green is used for 3D reconstruction. A, Axial CT image.

Fig 1A. 38-year-old female kidney donor. Segmentation of renal cortex. Only tissue not shaded green is used for 3D reconstruction. A, Axial CT image.
  • Juluru K, Rotman JA, Masi P, Spandorfer R, Ceraolo CA, Giambrone AE, Serur D, Hartono C

  • AJR Am J Roentgenol. 2015 May;204(5):W566-72.

2015-07-28

Fig 1. Chemical structures of compounds investigated in our study.

Fig 1. Chemical structures of compounds investigated in our study.
  • Brondfield S, Umesh S, Corella A, Zuber J, Rappaport AR, Gaillard C, Lowe SW, Goga A, Kogan SC

  • Cancer Chemother Pharmacol. 2015 Jul;76(1):35-46.
Open Access button

2015-07-29

Figure 1. Canonical and revised view of RAG binding.

Figure 1. Canonical and revised view of RAG binding.
  • Karo JM, Sun JC

  • Eur J Immunol. 2015 Jul;45(7):1906-15.

2015-07-30

FIG 1 Recombinant RnhC. (A) Primary structure

FIG 1 Recombinant RnhC. (A) Primary structure
  • Jacewicz A1, Shuman S

  • J Bacteriol. 2015 Aug 1;197(15):2489-98

2015-07-31

Figure 1. Examples of mouse prostate organoid and human prostate cancer organoid

Figure 1. Examples of mouse prostate organoid and human prostate cancer organoid
  • Gao D, Chen Y

  • Curr Opin Genet Dev. 2015 Feb;30:42-8.

2015-08-03

FIGURE 1. In vitro uptake of radiolabeled probes in human T cells transduced with different reporters.

FIGURE 1. In vitro uptake of radiolabeled probes in human T cells transduced with different reporters.
  • Moroz MA, Zhang H, Lee J, Moroz E, Zurita J, Shenker L, Serganova I, Blasberg R, Ponomarev V

  • J Nucl Med. 2015 Jul;56(7):1055-60

2015-08-04

Fig 1. Operating characteristics for hypothetical dose-toxicity curves and initial dose-toxicity curves in a trial design with 10 dose levels

Fig 1. Operating characteristics for hypothetical dose-toxicity curves and initial dose-toxicity curves in a trial design with 10 dose levels
  • Iasonos A, Gönen M, Bosl GJ

  • J Clin Oncol. 2015 Jul 1;33(19):2221-5.

2015-08-05

Figure 1: This work focuses on analyzing robustness with respect to pairwise interactions

Figure 1: This work focuses on analyzing robustness with respect to pairwise interactions
  • Sandhu R, Georgiou T, Reznik E, Zhu L, Kolesov I, Senbabaoglu Y, Tannenbaum A

  • Sci Rep. 2015 Jul 14;5:12323.

2015-08-06

Fig. 7. Proposed model for the role of association between p53 and BRCA1 in the regulation of HR activity.

Fig. 7. Proposed model for the role of association between p53 and BRCA1 in the regulation of HR activity.
  • Dong C, Zhang F, Luo Y, Wang H, Zhao X, Guo G, Powell SN, Feng Z

  • DNA Repair (Amst). 2015 Jun 24;33:60-69.

2015-08-07

Fig 7.  IL-4 and IL-13 blockade does not increase corneal angiogenesis.

Fig 7. IL-4 and IL-13 blockade does not increase corneal angiogenesis.
  • Savetsky IL, Ghanta S, Gardenier JC, Torrisi JS, García Nores GD, Hespe GE, Nitti MD, Kataru RP, Mehrara BJ

  • PLoS One. 2015 Jun 3;10(6):e0126908.
Open Access button

2015-08-10

Figure 1. Large numbers of preTs containing the transgene of a specific TCR under the regulation of an inducible promoter were generated in vitro.

Figure 1. Large numbers of preTs containing the transgene of a specific TCR under the regulation of an inducible promoter were generated in vitro.
  • Hoseini SS, Hapke M1, Herbst J, Wedekind D, Baumann R, Heinz N, Schiedlmeier B, Vignali DA, van den Brink MR, Schambach A, Blazar BR, Sauer MG

  • Leukemia. 2015 Jul;29(7):1530-42.

2015-08-11

Fig 1. Clinical activity in patients with non–small-cell lung cancer (NSCLC) receiving nivolumab. Kaplan-Meier curves of overall survival (OS) for (A) total patient population (N = 129) and (B) patients who received nivolumab 1 (n = 33), 3 (n = 37), or 10 mg/kg (n = 59).

Fig 1. Clinical activity in patients with non–small-cell lung cancer (NSCLC) receiving nivolumab. Kaplan-Meier curves of overall survival (OS) for (A) total patient population (N = 129) and (B) patients who received nivolumab 1 (n = 33), 3 (n = 37), or 10 mg/kg (n = 59).
  • Gettinger SN, Horn L, Gandhi L, Spigel DR, Antonia SJ, Rizvi NA, Powderly JD, Heist RS, Carvajal RD, Jackman DM, Sequist LV, Smith DC, Leming P, Carbone DP, Pinder-Schenck MC, Topalian SL, Hodi FS, Sosman JA, Sznol M, McDermott DF, Pardoll DM, Sankar V, Ahlers CM, Salvati M, Wigginton JM, Hellmann MD, Kollia GD, Gupta AK, Brahmer JR

  • J Clin Oncol. 2015 Jun 20;33(18):2004-12.

2015-08-12

Fig 1. Selected members of the oridamycin and xiamycin families.

Fig 1. Selected members of the oridamycin and xiamycin families.
  • Trotta AH

  • Org Lett. 2015 Jul 2;17(13):3358-61.

2015-08-13

Figure 1: Characterization of primary cultured NFs and CAFs

Figure 1: Characterization of primary cultured NFs and CAFs
  • Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X, Huang R, Yan J, Guo H

  • Sci Rep. 2015 Jul 8;5:11924.

2015-08-14

Fig 2. Menstrual status at protocol-specified time points.

Fig 2. Menstrual status at protocol-specified time points.
  • Ruddy KJ, Guo H, Barry W, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Hudis C, Krop IE, Burstein HJ, Winer EP, Partridge AH, Tolaney SM

  • Breast Cancer Res Treat. 2015 Jun;151(3):589-96.

2015-08-17

Figure 1. Physiological Levels of Extracellular Proteins Provide Nutritional Benefits for Wild-Type and K-Ras Mutant Cells

Figure 1. Physiological Levels of Extracellular Proteins Provide Nutritional Benefits for Wild-Type and K-Ras Mutant Cells
  • Palm W, Park Y, Wright K, Pavlova NN, Tuveson DA, Thompson CB

  • Cell. 2015 Jul 16;162(2):259-70.

2015-08-18

Fig 8. sem-2 affects the development of RME motor neurons.

Fig 8. sem-2 affects the development of RME motor neurons.
  • Vidal B, Santella A, Serrano-Saiz E, Bao Z, Chuang CF, Hobert O

  • Development. 2015 Jul 15;142(14):2464-77.

2015-08-19

Fig.2 ERBB2 immunohistochemistry and chromogenic in situ hybridization correlation.

Fig.2 ERBB2 immunohistochemistry and chromogenic in situ hybridization correlation.
  • Hechtman JF, Liu W, Sadowska J, Zhen L, Borsu L, Arcila ME, Won HH, Shah RH, Berger MF, Vakiani E, Shia J, Klimstra DS

  • Mod Pathol. 2015 Aug;28(8):1123-9.

2015-08-20

Fig 2. Basic Characteristics of Numerical Chromosomal Instability in Clonal Populations.

Fig 2. Basic Characteristics of Numerical Chromosomal Instability in Clonal Populations.
  • Laughney AM, Elizalde S, Genovese G, Bakhoum SF

  • Cell Rep. 2015 Aug 4;12(5):809-20.
Open Access button

2015-08-21

Fig 2. Metaplastic breast cancers of basal-like and claudin-low intrinsic subtypes are distinct at the molecular level.

Fig 2. Metaplastic breast cancers of basal-like and claudin-low intrinsic subtypes are distinct at the molecular level.
  • Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, Mariani O, Stern MH, Norton L, Vincent-Salomon A, Reis-Filho JS

  • Mod Pathol. 2015 Mar;28(3):340-51.

2015-08-24

Horizontal line profiles through centers of reconstructed images [Figs. 3(e)–3(h)] and ground truth [Fig. 1(c)]. Peaks at pixels 17 and 68 represent centers of Gaussian spheres with FWHM values 21.1 and 14.1 mm, respectively.

Horizontal line profiles through centers of reconstructed images [Figs. 3(e)–3(h)] and ground truth [Fig. 1(c)]. Peaks at pixels 17 and 68 represent centers of Gaussian spheres with FWHM values 21.1 and 14.1 mm, respectively.
  • Li S, Zhang J, Krol A, Schmidtlein CR, Vogelsang L, Shen L, Lipson E, Feiglin D, Xu Y

  • Med Phys. 2015 Aug;42(8):4872.

2015-08-25

Figure 2. Performance of the EC-NMR method.

Figure 2. Performance of the EC-NMR method.
  • Tang Y, Huang YJ, Hopf TA, Sander C, Marks DS, Montelione GT

  • Nat Methods. 2015 Aug;12(8):751-4.

2015-08-26

Fig 1. The structural characterization of EcEndoV.

Fig 1. The structural characterization of EcEndoV.
  • Zhang Z, Jia Q, Zhou C, Xie W

  • Sci Rep. 2015 Aug 5;5:12754.
Open Access button

2015-08-27

Fig 2. The clonality of tumor evolution.

Fig 2. The clonality of tumor evolution.
  • Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, Caldas C, Califano A, Doherty M, Elsner M, Esteller M, Fitzgerald R, Korbel JO, Lichter P, Mason CE, Navin N, Pe'er D, Polyak K, Roberts CW, Siu L, Snyder A, Stower H, Swanton C, Verhaak RG, Zenklusen JC, Zuber J, Zucman-Rossi J

  • Nat Med. 2015 Aug 6;21(8):846-53.

2015-08-28

Graphical Abstract

Graphical Abstract
  • Ren A, Rajashankar KR, Patel DJ

  • Structure. 2015 Aug 4;23(8):1375-81.

2015-08-31

Fig 4. A Low magnification image of the transverse section of the nerve and muscle at the site of ablation. Areas of ablation of the nerve and muscle are delineated. Note vascular hyperemia in the ablated portion of the nerve (arrow), and hemorrhage in the adjacent muscle (asterisk). Scale bar 1 mm. B High magnification, transverse section of the nerve at the site of ablation, (the area within the small box on image A. Note nuclear pyknosis of Schwann cells (arrow), with normal axons and myelin sheaths, and perineurial edema (asterisk) with hyalinization of collagen (arrowhead). Scale bar 20 μm. C High magnification, transverse section of nerve at site of ablation. Note nuclear pyknosis of Schwann cells (arrow), with dilated myelin sheaths and loss of axons (arrowhead), and perineurial edema (asterisk). Scale bar 20 μm. D High magnification, transverse section of nerve proximal to site of ablation. All structures are normal.

Fig 4. A Low magnification image of the transverse section of the nerve and muscle at the site of ablation. Areas of ablation of the nerve and muscle are delineated. Note vascular hyperemia in the ablated portion of the nerve (arrow), and hemorrhage in the adjacent muscle (asterisk). Scale bar 1 mm. B High magnification, transverse section of the nerve at the site of ablation, (the area within the small box on image A. Note nuclear pyknosis of Schwann cells (arrow), with normal axons and myelin sheaths, and perineurial edema (asterisk) with hyalinization of collagen (arrowhead). Scale bar 20 μm. C High magnification, transverse section of nerve at site of ablation. Note nuclear pyknosis of Schwann cells (arrow), with dilated myelin sheaths and loss of axons (arrowhead), and perineurial edema (asterisk). Scale bar 20 μm. D High magnification, transverse section of nerve proximal to site of ablation. All structures are normal.
  • Kaye EA, Gutta NB, Monette S, Gulati A, Loh J, Srimathveeravalli G, Ezell PC, Erinjeri JP, Solomon SB, Maybody M

  • Cardiovasc Intervent Radiol. 2015 Aug;38(4):985-92.

2015-09-01

Fig 1. Encapsulated follicular variant of papillary thyroid carcinoma. a Low-power view showing tumor (T) surrounded by its capsule (cap) with no invasion. b Medium-power view revealing follicular growth with densely eosinophilic colloid characteristic of papillary thyroid carcinoma follicular variant. c High-power view of the nuclear features of papillary thyroid carcinoma: hypochromatic, irregular, overlapping nuclei with grooves (the latter indicated by an arrow). d Mass spectrometry traces for NRAS codon 61 mutation from the tumor. Note the mutant NRAS 182G (indicated by M) and wild type (W) peaks (reprinted with permission from Rivera et al.

Fig 1. Encapsulated follicular variant of papillary thyroid carcinoma. a Low-power view showing tumor (T) surrounded by its capsule (cap) with no invasion. b Medium-power view revealing follicular growth with densely eosinophilic colloid characteristic of papillary thyroid carcinoma follicular variant. c High-power view of the nuclear features of papillary thyroid carcinoma: hypochromatic, irregular, overlapping nuclei with grooves (the latter indicated by an arrow). d Mass spectrometry traces for NRAS codon 61 mutation from the tumor. Note the mutant NRAS 182G (indicated by M) and wild type (W) peaks (reprinted with permission from Rivera et al.
  • Xu B, Ghossein R

  • Endocr Pathol. 2015 Sep;26(3):191-9.

2015-09-02

Fig 1. Type 1 superior thyroid pole featuring a narrow pyramid-shape superior pole with narrow vascular pedicle.

Fig 1. Type 1 superior thyroid pole featuring a narrow pyramid-shape superior pole with narrow vascular pedicle.
  • Mizrachi A, Swartzwelder CE, Shaha AR

  • J Surg Oncol. 2015 Jul;112(1):15-7.
Open Access button

2015-09-03

Fig 1. A Transverse and B sagittal contrast-enhanced CT images obtained in a 51-year-old woman with clear cell carcinoma of the uterine corpus demonstrate bulky endometrial tumor with deep myometrial invasion (arrow), dilation of the endocervical canal by the tumor and irregular interphase between the tumor and cervical stroma (arrowhead). C Transverse and D coronal contrast-enhanced CT images performed in a 49-year-old woman with clear cell carcinoma of the uterine corpus demonstrates deeply invasive tumor including frank cervical stromal invasion (arrowhead).

Fig 1. A Transverse and B sagittal contrast-enhanced CT images obtained in a 51-year-old woman with clear cell carcinoma of the uterine corpus demonstrate bulky endometrial tumor with deep myometrial invasion (arrow), dilation of the endocervical canal by the tumor and irregular interphase between the tumor and cervical stroma (arrowhead). C Transverse and D coronal contrast-enhanced CT images performed in a 49-year-old woman with clear cell carcinoma of the uterine corpus demonstrates deeply invasive tumor including frank cervical stromal invasion (arrowhead).
  • Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Miccò M, Zheng J, Moskowitz CS, Soslow RA, Hricak H, Abu-Rustum NR, Sala E

  • Abdom Imaging. 2015 Aug;40(6):1761-8.

2015-09-04

Graphical abstract

Graphical abstract
  • Dreser N, Zimmer B, Dietz C, Sügis E, Pallocca G, Nyffeler J, Meisig J, Blüthgen N, Berthold MR, Waldmann T, Leist M

  • Neurotoxicology. 2015 Jul 31;50:56-70.

2015-09-08

Fig 7. Central Role of Intestinal Mfs in Generation of Commensal-Induced Th17 Cells.

Fig 7. Central Role of Intestinal Mfs in Generation of Commensal-Induced Th17 Cells.
  • Panea C, Farkas AM, Goto Y, Abdollahi-Roodsaz S, Lee C, Koscsó B, Gowda K, Hohl TM, Bogunovic M, Ivanov II

  • Cell Rep. 2015 Aug 25;12(8):1314-24.
Open Access button

2015-09-09

Fig 1. Two concepts of using oncolytic virus for cancer treatment.

Fig 1. Two concepts of using oncolytic virus for cancer treatment.
  • Zamarin D, Pesonen S

  • Hum Gene Ther. 2015 Aug;26(8):538-49.
Open Access button

2015-09-10

Fig 4. H&E staining of infected lungs at 24 h following infection.

Fig 4. H&E staining of infected lungs at 24 h following infection.
  • Xiong H, Carter RA, Leiner IM, Tang YW, Chen L, Kreiswirth BN, Pamer EG

  • Infect Immun. 2015 Sep;83(9):3418-27.

2015-09-11

Fig 1. MRI and autopsy findings.

Fig 1. MRI and autopsy findings.
  • Faivre G, Pentsova E, Demopoulos A, Taillibert S, Rosenblum M, Omuro A

  • Neurology. 2015 Aug 18;85(7):e57-61.
Open Access button

2015-09-14

Fig 2. Schematic of the methodology for acquiring hyperpolarized 13C metabolite DW images and generating ADC maps. The example data shown are of a hyperpolarized 13C pyruvate phantom at 22°C.

Fig 2. Schematic of the methodology for acquiring hyperpolarized 13C metabolite DW images and generating ADC maps. The example data shown are of a hyperpolarized 13C pyruvate phantom at 22°C.
  • Koelsch BL, Reed GD, Keshari KR, Chaumeil MM, Bok R, Ronen SM, Vigneron DB, Kurhanewicz J, Larson PE

  • Magn Reson Med. 2015 Sep;74(3):622-33.

2015-09-15

Fig 7. A Model for Recruitment of Aub and Ago3 to Nuage and Formation of the 4P Complex.

Fig 7. A Model for Recruitment of Aub and Ago3 to Nuage and Formation of the 4P Complex.
  • Webster A, Li S, Hur JK, Wachsmuth M, Bois JS, Perkins EM, Patel DJ, Aravin AA

  • Mol Cell. 2015 Aug 20;59(4):564-75.
Open Access button

2015-09-16

Figure 1. Immunofluorescence staining to determine BRCA1 subcellular expression.

Figure 1. Immunofluorescence staining to determine BRCA1 subcellular expression.
  • Santivasi WL, Wang H, Wang T, Yang Q, Mo X, Brogi E, Haffty BG, Chakravarthy AB, Xia F

  • Br J Cancer. 2015 Jul 28;113(3):453-9.

2015-09-17

Fig 2. Maximum Percent Change from Baseline in the Sum of the Diameters of Target Lesions.

Fig 2. Maximum Percent Change from Baseline in the Sum of the Diameters of Target Lesions.
  • Hyman DM, Puzanov I, Subbiah V, Faris JE, Chau I, Blay JY, Wolf J, Raje NS, Diamond EL, Hollebecque A, Gervais R, Elez-Fernandez ME, Italiano A, Hofheinz RD, Hidalgo M, Chan E, Schuler M, Lasserre SF, Makrutzki M, Sirzen F, Veronese ML, Tabernero J, Baselga J

  • N Engl J Med. 2015 Aug 20;373(8):726-36.

2015-09-18

Fig 1. Scatter plot of all sirolimus concentrations, with a lowess local regression curve (red). The suggested therapeutic range of 3–12 ng/mL and the median concentration is outlined for reference.

Fig 1. Scatter plot of all sirolimus concentrations, with a lowess local regression curve (red). The suggested therapeutic range of 3–12 ng/mL and the median concentration is outlined for reference.
  • Ceberio I, Dai K, Devlin SM, Barker JN, Castro-Malaspina H, Goldberg JD, Giralt S, Adel NG, Perales MA

  • Bone Marrow Transplant. 2015 Mar;50(3):438-43.

2015-09-21

Fig 1. Medical oncologists’ estimated distributions of patient attitudes for research purpose-only biopsies (RPOBs) of the breast (A) and RPOBs of the liver (B).

Fig 1. Medical oncologists’ estimated distributions of patient attitudes for research purpose-only biopsies (RPOBs) of the breast (A) and RPOBs of the liver (B).
  • Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU

  • Oncologist. 2015 Sep;20(9):992-1000.

2015-09-22

Fig 2. Proportion and number of DCIS cases undergoing breast-conserving surgery versus therapeutic mastectomy, by year.

Fig 2. Proportion and number of DCIS cases undergoing breast-conserving surgery versus therapeutic mastectomy, by year.
  • Subhedar P, Olcese C, Patil S, Morrow M, J Van Zee K

  • Ann Surg Oncol. 2015 Oct;22(10):3273-81.

2015-09-23

Fig 7.1. The NK cell response against MCMV. A subset of natural killer cells in the C57BL/6 mouse express the activating receptor Ly49H, which recognizes the MCMV-encoded glycoprotein m157.

Fig 7.1. The NK cell response against MCMV. A subset of natural killer cells in the C57BL/6 mouse express the activating receptor Ly49H, which recognizes the MCMV-encoded glycoprotein m157.
  • Beaulieu AM, Madera S, Sun JC

  • Adv Exp Med Biol. 2015;850:81-91.

2015-09-24

Fig 1. Distribution of mutations detected in DASISION at 3 years by treatment arm and BCR-ABL1 location.

Fig 1. Distribution of mutations detected in DASISION at 3 years by treatment arm and BCR-ABL1 location.
  • Hughes TP, Saglio, G, Quintás-Cardama A, Mauro MJ, Kim DW, Lipton JH, Bradley-Garelik M, Ukropec J, Hochhaus A

  • Leukemia 2015 Sept; 29 (9): 1832-1838.
Open Access button

2015-09-25

Fig 1. Effects of decreased mitochondrial-protein import.

Fig 1. Effects of decreased mitochondrial-protein import.
  • Haynes CM

  • Nature. 2015 Aug 27;524(7566):419-20.

2015-09-28

P417 resides in the SBD. After sequence alignment, the location of Pro417 (P417) was mapped onto the structure of the E. coli protein DnaK using Protein Data bank file 2KHO.

P417 resides in the SBD. After sequence alignment, the location of Pro417 (P417) was mapped onto the structure of the E. coli protein DnaK using Protein Data bank file 2KHO.
  • Needham PG, Patel HJ, Chiosis G, Thibodeau PH, Brodsky JL

  • J Mol Biol. 2015 Sep 11;427(18):2948-65.

2015-09-29

Fig 4. Two motifs in Esco1 mediate its association with cohesin and gene-silencing activity.

Fig 4. Two motifs in Esco1 mediate its association with cohesin and gene-silencing activity.
  • Rahman S, Jones MJ, Jallepalli PV

  • Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11270-5.

2015-09-30

Fig 4. Absorbed dose modeling. Dose distribution profiles, generated by Metropolis for a 15-Gy arc therapy, with crosshairs showing the treatment center in coronal (A), transverse (B), and sagittal planes (C). The tumor is outlined in purple. (D) Dose-volume histogram for the tumor in the arc treatment plan.

Fig 4. Absorbed dose modeling. Dose distribution profiles, generated by Metropolis for a 15-Gy arc therapy, with crosshairs showing the treatment center in coronal (A), transverse (B), and sagittal planes (C). The tumor is outlined in purple. (D) Dose-volume histogram for the tumor in the arc treatment plan.
  • Thorek DL, Kramer RM, Chen Q, Jeong J, Lupu ME, Lee AM, Moynahan ME, Lowery M, Ulmert D, Zanzonico P, Deasy JO, Humm JL, Russell J

  • Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):444-53.

2015-10-01

Fig 1. Recurrent CDKN1B mutations in classical HCL.

Fig 1. Recurrent CDKN1B mutations in classical HCL.
  • Dietrich S, Hüllein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oleś M, Else M, Liu X, Słabicki M, Wu B, Troussard X, Dürig J, Andrulis M, Dearden C, von Kalle C, Granzow M, Jauch A, Fröhling S, Huber W, Meggendorfer M, Haferlach T, Ho AD, Richter D, Brors B, Glimm H, Matutes E, Abdel Wahab O, Zenz T

  • Blood. 2015 Aug 20;126(8):1005-8.